Jan 26, 2021
Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta
Jan 12, 2021
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories
Jan 07, 2021
Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics
Aug 06, 2020
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development
Oct 29, 2019
Caprion Biosciences Leads Pre-Conference Workshop on Best Practices for Biomarkers Validation at Upcoming AAPS PharmaSci 360 Conference
Jul 31, 2019
Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development
Apr 30, 2019
Caprion Biosciences expands its global biomarker and immune monitoring franchise by acquiring Serametrix Corporation
Apr 25, 2019
Roche Presented Caprion Biosciences' Data on Targeted Mass Spectrometry for Clinical Proteomics
Aug 21, 2018
Caprion Biosciences Expands its Biomarker and Immune Monitoring Franchise by Acquiring US-Based Primity Bio
Sep 13, 2017
Caprion Biosciences Receives College of American Pathologists (CAP) Accreditation & Clinical Laboratory Improvement Amendments (CLIA) Certification
Aug 23, 2017
Caprion Biosciences and the FNIH Biomarkers Consortium Partner to Improve Monitoring of Early Alzheimer's Disease Progression and Treatment Response
Jul 26, 2017
Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections